Keyphrases
Adult Patients
100%
Acute Respiratory Distress Syndrome
100%
Phase II Trial
100%
Partial Liquid Ventilation
100%
Gas Exchange
50%
FiO2
33%
Extracorporeal Life Support
33%
PaO2
16%
Intratracheal
16%
Severe Respiratory Failure
16%
Hypoxia
16%
Adverse Events
16%
Total Dose
16%
Hemodynamic Parameters
16%
Hyperbilirubinemia
16%
Pulmonary Hemodynamics
16%
Pulmonary Compliance
16%
SvO2
16%
Perflubron
16%
First-year Experience
16%
Severe Adverse Effects
16%
Medicine and Dentistry
Acute Respiratory Distress Syndrome
100%
Liquid Ventilation
100%
Gas Exchange
50%
Adverse Event
33%
Analysis of Variance
33%
Extracorporeal Life Support
33%
Hypoxia
16%
Respiratory Failure
16%
Hyperbilirubinemia
16%
Pulmonary Compliance
16%
Lung Hemodynamics
16%
Perflubron
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Adult Respiratory Distress Syndrome
100%
Hypoxia
50%
Hyperbilirubinemia
50%
Respiratory Failure
50%
Perfluorooctyl Bromide
50%